Methoxyflurane Analgesia in Adult Patients in the Emergency Department: A Subgroup Analysis of a Randomized, Double-blind, Placebo-controlled Study (STOP!)

Frank Coffey, Patrick Dissmann, Kazim Mirza, Mark Lomax, Frank Coffey, Patrick Dissmann, Kazim Mirza, Mark Lomax

Abstract

Introduction: Acute pain remains highly prevalent in the Emergency Department (ED) setting. This double-blind, randomized, placebo-controlled UK study investigated the efficacy and safety of low-dose methoxyflurane analgesia for the treatment of acute pain in the ED in the adult population of the STOP! trial.

Methods: Patients presenting to the ED requiring analgesia for acute pain (pain score of 4-7 on the Numerical Rating Scale) due to minor trauma were randomized in a 1:1 ratio to receive methoxyflurane (up to 6 mL) or placebo (normal saline), both via a Penthrox® (Medical Developments International Limited, Scoresby, Australia) inhaler. Rescue medication (paracetamol/opioids) was available immediately upon request. Change from baseline in visual analog scale (VAS) pain intensity was the primary endpoint.

Results: 300 adult and adolescent patients were randomized; data are presented for the adult subgroup (N = 204). Mean baseline VAS pain score was ~66 mm in both groups. The mean change from baseline to 5, 10, 15 and 20 min was greater for methoxyflurane (-20.7, -27.4, -33.3 and -34.8 mm, respectively) than placebo (-8.0, -11.1, -12.3 and -15.2 mm, respectively). The primary analysis showed a highly significant treatment effect overall across all four time points (-17.4 mm; 95% confidence interval: -22.3 to -12.5 mm; p < 0.0001). Median time to first pain relief was 5 min with methoxyflurane [versus 20 min with placebo; (hazard ratio: 2.32; 95% CI: 1.63, 3.30; p < 0.0001)]; 79.4% of methoxyflurane-treated patients experienced pain relief within 1-10 inhalations. 22.8% of placebo-treated patients requested rescue medication within 20 min compared with 2.0% of methoxyflurane-treated patients (p = 0.0003). Methoxyflurane treatment was rated 'Excellent', 'Very Good' or 'Good' by 77.6% of patients, 74.5% of physicians and 72.5% of nurses. Treatment-related adverse events (mostly dizziness/headache) were reported by 42.2% of patients receiving methoxyflurane and 14.9% of patients receiving placebo; none caused withdrawal and the majority were mild and transient.

Conclusion: The results of this study support the evidence from previous trials that low-dose methoxyflurane administered via the Penthrox inhaler is a well-tolerated, efficacious and rapid-acting analgesic.

Funding: Medical Developments International (MDI) Limited and Mundipharma Research GmbH & Co.KG.

Trial registration: Clinicaltrials.gov identifier: NCT01420159, EudraCT number: 2011-000338-12.

Keywords: Acute pain; Analgesic; Emergency Department; Inhaled analgesic; Methoxyflurane; Pain; Penthrox, pre-hospital; Trauma.

Figures

Fig. 1
Fig. 1
Participant flow. NRS numerical rating scale, ITT intention-to-treat population. The ITT population is defined as those patients in the safety population who have at least one post-baseline efficacy assessment

References

    1. Ventafridda V, Saita L, Ripamonti C, De Conno F. WHO guidelines for the use of analgesics in cancer pain. Int J Tissue React. 1985;7:93–96.
    1. Cordell WH, Keene KK, Giles BK, Jones JB, Jones JH, Brizendine EJ. The high prevalence of pain in emergency medical care. Am J Emerg Med. 2002;20:165–169. doi: 10.1053/ajem.2002.32643.
    1. Berben SA, Meijs TH, van Dongen RT, et al. Pain prevalence and pain relief in trauma patients in the Accident and Emergency Department. Injury. 2008;39:578–585. doi: 10.1016/j.injury.2007.04.013.
    1. Pierik JG, IJzerman MJ, Gaakeer MI, et al. Pain management in the emergency chain: the use and effectiveness of pain management in patients with acute musculoskeletal pain. Pain Med. 2015;16:970–984. doi: 10.1111/pme.12668.
    1. Guéant S, Taleb A, Borel-Kühner J, et al. Quality of pain management in the emergency department: results of a multicentre prospective study. Eur J Anaesthesiol. 2011;28:97–105. doi: 10.1097/EJA.0b013e3283418fb0.
    1. Dale J, Bjørnsen LP. Assessment of pain in a Norwegian Emergency Department. Scand J Trauma Resusc Emerg Med. 2015;23:86. doi: 10.1186/s13049-015-0166-3.
    1. Lord BA, Parsell B. Measurement of pain in the prehospital setting using a visual analogue scale. Prehosp Disaster Med. 2003;18:353–358. doi: 10.1017/S1049023X0000131X.
    1. Tomlin PJ. Methoxyflurane. Br J Anaesth. 1965;37:706–709. doi: 10.1093/bja/37.9.706.
    1. Crandell WB, Pappas SG, Macdonald A. Nephrotoxicity associated with methoxyflurane anaesthesia. Anesthesiology. 1966;27:591–607. doi: 10.1097/00000542-196609000-00010.
    1. Mazze RI, Shue GL, Jackson SH. Renal dysfunction associated with methoxyflurane anaesthesia: a randomised, prospective clinical evaluation. JAMA. 1971;216:278–288. doi: 10.1001/jama.1971.03180280032006.
    1. Mazze RI. Methoxyflurane revisited: tale of an anaesthetic from cradle to grave. Anesthesiology. 2006;105:843–846. doi: 10.1097/00000542-200610000-00031.
    1. Tomi K, Mashimo T, Tashiro C, et al. Alterations in pain threshold and psychomotor response associated with subanaesthetic concentrations of inhalation anaesthetics in humans. Br J Anaesth. 1993;70:684–686. doi: 10.1093/bja/70.6.684.
    1. Penthrox European Summary of Product Characteristics October 2015. . Accessed 07 Aug 2016.
    1. Cousins ML, Mazze RI. Methoxyflurane nephrotoxicity. A study of dose-response in man. JAMA. 1973;225:1611–1616. doi: 10.1001/jama.1973.03220410023005.
    1. Mazze RI, Cousins ML. Biotransformation of methoxyflurane. Int Anesthesiol. 1984;2:551–575.
    1. Jacobs IG. Health effects of patient given methoxyflurane in the pre-hospital setting: a Data Linkage Study. Open Emerg Med J. 2010;3:7–13. doi: 10.2174/1876542401003010007.
    1. Dayan AD. Analgesic use of inhaled methoxyflurane: evaluation of its potential nephrotoxicity. Hum Exp Toxicol. 2016;35:91–100. doi: 10.1177/0960327115578743.
    1. Grindlay J, Babl FE. Review article: efficacy and safety of methoxyflurane analgesia in the emergency department and prehospital setting. Emerg Med Australas. 2009;21:4–11. doi: 10.1111/j.1742-6723.2009.01153.x.
    1. Johnston S, Wilkes GJ, Thompson JA, Ziman M, Brightwell R. Inhaled methoxyflurane and intranasal fentanyl for prehospital management of visceral pain in an Australian ambulance service. Emerg Med J. 2011;28:57–63. doi: 10.1136/emj.2009.078717.
    1. Buntine P, Thom O, Babl F, Bailey M, Bernard S. Prehospital analgesia in adults using inhaled methoxyflurane. Emerg Med Australas. 2007;19:509–514. doi: 10.1111/j.1742-6723.2007.01017.x.
    1. Gaskell AL, Jephcott CG, Smithells JR, Sleigh JW. Self-administered methoxyflurane for procedural analgesia: experience in a tertiary Australasian centre. Anaesthesia. 2016;71:417–423. doi: 10.1111/anae.13377.
    1. Coffey F, Wright J, Hartshorn S, et al. STOP!: a randomised, double-blind, placebo-controlled study of the efficacy and safety of methoxyflurane for the treatment of acute pain. Emerg Med J. 2014;31:613–618. doi: 10.1136/emermed-2013-202909.
    1. CHMP guideline CPMP/EWP/612/00. Note for Guidance on Clinical Investigations of Medicinal Products for Treatment of Nociceptive Pain.
    1. Jensen MP, Karoly P. The measurement of clinical pain intensity: a comparison of six methods. Pain. 1986;27:117–126. doi: 10.1016/0304-3959(86)90228-9.
    1. Ho K, Spence J, Murphy M. Review of pain measurement tools. Ann Emerg Med. 1996;27:427–431. doi: 10.1016/S0196-0644(96)70223-8.
    1. Gallagher EJ, Liebman M, Bijur PE. Prospective validation of clinically important changes in pain severity measured on a visual analog scale. Ann Emerg Med. 2001;38:633–638. doi: 10.1067/mem.2001.118863.
    1. Collins S, Moore A, McQuay H. The visual analog pain intensity scale: what is moderate pain in millimetres? Pain. 1997;72:95–97. doi: 10.1016/S0304-3959(97)00005-5.
    1. Todd KH, Funk KG, Funk JP, et al. Clinical significance of reported changes in pain severity. Ann Emerg Med. 1996;27:485–489. doi: 10.1016/S0196-0644(96)70238-X.
    1. Farrar JT, Young JP, Jr, LaMoreaux L, et al. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain. 2001;94:149–158. doi: 10.1016/S0304-3959(01)00349-9.
    1. Feinstein AR. Clinical epidemiology: the architecture of clinical research. Philadelphia: WB Saunders; 1985. pp. 396–406.
    1. Borland M, Jacobs I, King B, O’Brien D. A randomized controlled trial comparing intranasal fentanyl to intravenous morphine for managing acute pain in children in the emergency department. Ann Emerg Med. 2007;49:335–340. doi: 10.1016/j.annemergmed.2006.06.016.
    1. Tvieta T, Thoner J, Klepstad P, Dale O, Jystad A, Borchgrevink PC. A controlled comparison between single doses of intravenous and intramuscular morphine with respect to analgesic effects and patient safety. Acta Anaesthesiol Scand. 2008;52:920–925. doi: 10.1111/j.1399-6576.2008.01608.x.
    1. Nguyen NQ, Toscano L, Lawrence M, et al. Patient-controlled analgesia with inhaled methoxyflurane versus conventional endoscopist-provided sedation for colonoscopy: a randomized multicenter trial. Gastrointest Endosc. 2013;78:892–901. doi: 10.1016/j.gie.2013.05.023.
    1. Nguyen NQ, Toscano L, Lawrence M, et al. Portable inhaled methoxyflurane is feasible and safe for colonoscopy in subjects with morbid obesity and/or obstructive sleep apnea. Endosc Int Open. 2015;3:E487–E493. doi: 10.1055/s-0034-1392366.
    1. Spruyt O, Westerman D, Milner A, Bressel M, Wein S. A randomised, double-blind, placebo-controlled study to assess the safety and efficacy of methoxyflurane for procedural pain of a bone marrow biopsy. BMJ Support Palliat Care. 2014;4:342–348. doi: 10.1136/bmjspcare-2013-000447.
    1. Huang S, Pepdjonovic L, Konstantatos A, Frydenberg M, Grummet J. Penthrox alone versus Penthrox plus periprostatic infiltration of local analgesia for analgesia in trasrectal ultrasound-guided prostate biopsy. ANZ J Surg. 2016;86:139–142. doi: 10.1111/ans.12974.
    1. Oxer HF. Effects of Penthrox® (methoxyflurane) as an analgesic on cardiovascular and respiratory functions in the pre-hospital setting. J Military Veterans’ Health. 2016;24(2):14–20.
    1. Carley S, Body R. Methoxyflurane is a better painkiller than placebo: but do we want to know more? Emerg Med J. 2014;31:610. doi: 10.1136/emermed-2014-203690.
    1. Ethical Considerations for Clinical Trials on Medicinal Products Conducted with the Paediatric Population. 2008. . Accessed 07 Aug 2016.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться